Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Activating cannabinoid receptor 1 reduces certain keratin levels, potentially aiding psoriasis treatment.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Finasteride reduces pain in male rats and works better with testosterone.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Duloxetine, escitalopram, and finasteride may be effective against bacteria and fungi.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

GI197111X is best dissolved in Capmul MCM for trials.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

RORA affects hair follicle stem cells' structure and movement, potentially helping treat hair loss.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.